Occlusion devices and methods of their manufacture and use

ABSTRACT

Disclosed are implantable medical devices for the occlusion of a bodily lumen, cavity, vessel, or organ, as well as methods for manufacturing such occlusion devices, and methods for treating a subject using the occlusion devices. The devices generally include a wire having shape memory properties and a flexible membranous material disposed about the wire. Some embodiments include a lateral fringe on the membranous material. Some embodiments include a fluid capture cup affixed to the wire.

CROSS-REFERENCE TO RELATED APPLICATIONS

This application claims the benefit of priority of U.S. ProvisionalApplication No. 61/586,633, filed Jan. 13, 2012. The disclosure of theprior application is considered part of (and is incorporated byreference in) the disclosure of this application.

TECHNICAL FIELD

This disclosure relates generally to medical devices, and morespecifically to devices for occlusion of a bodily lumen, cavity, vessel,or organ.

BACKGROUND

Many clinical situations require the reduction or complete stoppage offluid flow (e.g., blood flow) in some region of a patient's body.Treatments for aneurysms, arteriovenous malformations, traumaticfistulae, and tumor embolization provide a few notable examples. Theseand other conditions often require that the fluid flow through at leasta portion of a bodily lumen, cavity, vessel, or organ be blocked.

Occluders, plugs, and embolic coils are examples of devices that can beimplanted in a patient to block fluid flow in a lumen, cavity, or organ.In some cases, the implanted device alone sufficiently provides thedesired blockage. In some cases, the implanted device inducesthrombosis, and the combination of the device and the thrombus providethe desired blockage. For example, vascular occlusion devices may bedeployed within a blood vessel at the site of an aneurysm, or within theaneurysm, of the brain or limbs. During deployment, the configuration ofthe device may change to an operational size and shape to reduce theflow of blood through the weakened section of the blood vessel. Thrombusmay form on the occlusion device to further seal off blood flow in thearea of the aneurysm, thereby preventing its ballooning or rupture. Atypical intracranial procedure would consist of placing one or morecoils into the aneurysm to fill the void, thus causing thrombus to form,and reducing the pressure within the aneurysm. Often this is donethrough a stent or “stentriever” to help prevent protrusion of the coilinto the lumen of the vessel.

An embolic coil is a type of vascular occlusion device. Embolic coilscan be constructed from a biocompatible metal wire, such as a shapememory metal alloy. Use of a shape memory material may allow the deviceto be arranged in a low-profile configuration for transcatheterdeployment, and for the device to expand to an operational size andshape when deployed at the target location within the patient'svasculature.

SUMMARY

This disclosure provides implantable medical devices for the occlusionof a bodily lumen, cavity, vessel, or organ. This disclosure alsoprovides methods for manufacturing such occlusion devices, and methodsfor treating a subject using the occlusion devices.

Particular embodiments of the subject matter described in thisspecification can be implemented so as to realize one or more of thefollowing advantages. In some embodiments, the implantable occlusiondevices are functionally enhanced by the inclusion of membranousmaterials to increase the profile size and the thrombogenicity of theocclusion devices. In some embodiments, the membranous material on theocclusion devices is configured as multiple elongated fringe members toenhance the profile size and the thrombogenicity of the occlusiondevices. In some embodiments, the occlusion devices are functionallyenhanced by the inclusion of a membranous cup-shaped portion configuredin an everted arrangement that substantially blocks fluid flow frompassing through the occlusion device.

Disclosed are devices for full or partial occlusion of a lumen, cavity,vessel, or organ in a bodily tissue. The devices provided herein can beused to treat, for example, aneurysms, arteriovenous malformations,traumatic fistulae, endoleaks, wounds, various cancers, and many otherconditions. The disclosed devices include, for example, occluders,coils, and plugs. In some embodiments, the occlusion devices providedherein include at least one wire and a membranous material. In someembodiments, the membranous material is disposed around the wire (e.g.,by wrapping) and may be incised along at least a portion of its lengthto form a fringe extending outwardly from and exterior to the wire. Theincisions effectively generate an external fringe having filaments orstrips extending along the wire. In some embodiments, for example thoseincluding an elastomeric membranous material, the occlusion devicesprovided herein are not incised to form fringes. In some embodiments,the occlusion devices provided herein include a cup formed of themembranous material. In some embodiments, the cup is adapted tosubstantially block fluid flow through the device to aid in occluding orlimiting fluid flow through the lumen.

In one general aspect, an implantable occlusion device comprises atleast one wire having shape memory properties and a flexible polymersheet; the sheet is disposed around the wire, and the sheet includes anexternal fringe along at least a portion of a length of the sheet.

In various implementations the external fringe may comprise an incisedportion of the sheet; at least a portion of the fringe may benon-integral to the sheet; the fringe may extend substantially an entirelength of the wire; the sheet may be attached to the wire at one or morelocations on the wire; the sheet may comprise ePTFE; the implantableocclusion device may further comprise an endothelization promotingagent, anti-inflammatory agent, or a healing agent; and the implantableocclusion device may further comprise one or more radiopaque markers.

In a second general aspect, an implantable occlusion device comprises atleast one wire having shape memory properties and a flexible polymertube; the tube is disposed around the wire, and the tube includes anexternal fringe along at least a portion of a length of the tube.

In various implementations at least a portion of the wire may be locatedinside a lumen of the tube; the tube may comprise a polymer strip thatis wrapped around at least a portion of the wire; the external fringemay comprise an incised portion of the tube; at least a portion of thefringe may be non-integral to the tube; the fringe may extendsubstantially an entire length of the wire; the fringe may have a lengththat extends beyond a length of the wire; the tube may be attached tothe wire at one or more locations on the wire; the tube may compriseePTFE; the implantable occlusion device may further comprise anendothelization promoting agent, anti-inflammatory agent, or a healingagent; and the implantable occlusion device may further comprise one ormore radiopaque markers.

In a third general aspect, a method of making an implantable occlusiondevice comprises providing at least one shape memory wire and formingthe shape memory wire into a coil, the coil having an overall outsidediameter and a coil length; providing a flexible polymeric tube, theflexible polymeric tube having an inside diameter that is smaller thanthe overall outside diameter of the coil; elongating the coil, whereinthe elongated coil has an elongated coil length that is greater than thecoil length, and wherein the elongated coil has an elongated coildiameter that is less than the overall outside diameter of the coil;fitting the flexible polymeric tube over the elongated coil; andallowing the elongated coil to recoil to a contracted length, whereinthe contracted length is less than the elongated coil length, therebycausing the flexible polymeric tube to form an irregular shape usefulfor occlusion.

In various implementations the coil may be a substantially helical coil;the flexible polymeric material may comprise ePTFE; the method of makingan implantable occlusion device may further comprise attaching theflexible polymeric material to the elongated coil prior to allowing theelongated helical coil to recoil to the contracted length; the method ofmaking an implantable occlusion device may further comprise attachingthe flexible polymeric material to the elongated coil on an entirelength of the wire; the method of making an implantable occlusion devicemay further comprise attaching the flexible polymeric material to theelongated coil at multiple discrete attachment points along a length ofthe elongated coil; the method of making an implantable occlusion devicemay further comprise attaching the flexible polymeric material to theelongated coil using an adhesive; and the method of making animplantable occlusion device may further comprise, prior to allowing theelongated coil to recoil to the contracted length, incising the flexiblepolymeric material to create a fringe portion along at least a portionof a length of the flexible polymeric material.

In a fourth general aspect, a device for limiting fluid flow through alumen in a bodily tissue comprises at least one wire with proximal anddistal ends; and a flexible polymeric cup, wherein the flexiblepolymeric cup includes an open end affixed to the proximal end of thewire, wherein the flexible polymeric cup is adapted to be reconfiguredduring deployment into the lumen from a pre-deployed state to an evertedstate, and wherein the flexible polymeric cup in the everted state isadapted to limit fluid flow through the lumen.

In various implementations the flexible polymeric cup may be formed froma sheet of polymeric material; the flexible polymeric cup may be formedfrom a tube of polymeric material; the flexible polymeric cup maycomprise ePTFE; the device for limiting fluid flow through a lumen in abodily tissue may further comprise one or more radiopaque markers; andthe device for limiting fluid flow through a lumen in a bodily tissuemay further comprise a flexible polymeric material, the flexiblepolymeric material may be disposed around the wire, and the flexiblepolymeric material may include an external fringe along at least aportion of a length of the flexible polymeric material.

In a fifth general aspect, a method for occluding a lumen in a bodilytissue comprises providing an occlusion device, wherein the occlusiondevice comprises: at least one wire with proximal and distal ends and aflexible polymeric cup, wherein the flexible polymeric cup includes anopen end affixed to the proximal end of the wire, wherein the flexiblepolymeric cup is adapted to be reconfigured during deployment into thelumen from a pre-deployed state to an everted state, and wherein theflexible polymeric cup in the everted state is adapted to occlude thelumen; providing a delivery sheath, wherein the delivery sheathcomprises a delivery lumen; configuring, within the delivery lumen, theocclusion device in the pre-deployed state; delivering the deliverylumen including the occlusion device in the pre-deployed state to atarget site within the lumen; and deploying the occlusion device at thetarget site within the lumen, wherein the deploying comprises: ejectingthe occlusion device from the delivery lumen and reconfiguring theflexible polymeric cup from the pre-deployed state to the everted state.

In various implementations the reconfiguring of the flexible polymericcup from the pre-deployed state to the everted state may be caused atleast partially by pressure exerted by fluid against the flexiblepolymeric cup; and the reconfiguring of the flexible polymeric cup fromthe pre-deployed state to the everted state may be caused at leastpartially by pressure exerted by a device against the flexible polymericcup.

In a sixth general aspect, a method of making an implantable occlusiondevice comprises providing at least one shape memory wire; forming theshape memory wire into a cup frame, the cup frame having an overalloutside diameter and open proximal and distal ends; and affixing aflexible polymeric cup to the proximal end of the cup frame, wherein theflexible polymeric cup includes an open end and a closed end, whereinthe open end is affixed to the cup frame, wherein the flexible polymericcup is adapted to be reconfigured during implantation in a bodily lumenfrom a pre-deployed state to an everted state, and wherein the flexiblepolymeric cup in the everted state is adapted to occlude the lumen.

In various implementations the method of making an implantable occlusiondevice may further comprise forming the shape memory wire into a coil,wherein the coil may have an overall outside diameter and a coil length;elongating the coil, wherein the elongated coil may have an elongatedcoil length that is greater than the coil length, and wherein theelongated coil may have an elongated coil diameter that is less than theoverall outside diameter of the coil; fitting a flexible polymeric tubeover the elongated coil, the flexible polymeric tube may have an insidediameter that is less than the overall outside diameter of the coil; andallowing the elongated coil to recoil to a contracted length, whereinthe contracted length may be less than the elongated coil length,thereby causing the flexible polymeric tube to form an irregular shapeuseful for occlusion; the method of making an implantable occlusiondevice may further comprise, prior to allowing the elongated coil torecoil, incising the flexible polymeric tube to create a fringe portionalong at least a portion of a length of the flexible polymeric tube; themethod of making an implantable occlusion device may further compriseforming the shape memory wire into a coil, wherein the coil may have anoverall outside diameter; elongating the coil, thereby increasing alength of the coil to an elongated length and reducing the overalloutside diameter of the coil; wrapping a flexible polymeric materialonto the elongated coil, wherein the elongated coil may be substantiallycovered by the flexible polymeric material, and wherein portions of theflexible polymeric material may not be in direct contact with theelongated coil; and allowing the elongated coil to recoil to acontracted length, wherein the contracted length may be less than theelongated length, thereby causing the flexible polymeric material toform an irregular shape useful for occlusion; and the method of makingan implantable occlusion device may further comprise, prior to allowingthe elongated coil to recoil, incising the flexible polymeric materialto create a fringe portion along at least a portion of a length of theflexible polymeric material.

Other aspects, features, and advantages will be apparent from thedescription, the drawings, and the claims.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 depicts an elongate member of an example occlusion device in arelaxed configuration and a low-profile configuration.

FIG. 2 depicts an example occlusion device in a low-profileconfiguration.

FIG. 3 depicts an example occlusion device in a low-profileconfiguration and a relaxed configuration.

FIG. 4 depicts an example occlusion device in a low-profileconfiguration and a relaxed configuration.

FIG. 5 depicts an example occlusion device in a low-profileconfiguration and a relaxed configuration.

FIGS. 6A-6F illustrate examples of wire coil configurations for use inocclusion devices.

FIG. 7 depicts an elongate member frame of an example cup-shapedocclusion device in a relaxed configuration and a low-profileconfiguration.

FIG. 8 depicts an example cup-shaped occlusion device in a stretchedconfiguration and a relaxed configuration.

FIG. 9 depicts an example cup-shaped occlusion device in a stretchedconfiguration and a relaxed configuration.

FIGS. 10A-10D illustrate an example deployment process of an examplecup-shaped occlusion device in a bodily vessel.

FIG. 11 is a flowchart of an example process for making a coil occlusiondevice.

FIG. 12 is a flowchart of an example process for making a cup-frameocclusion device.

FIG. 13 is a flowchart of an example method of implanting an occlusiondevice in the body of a patient.

Like reference symbols in the various drawings indicate like elements.

DETAILED DESCRIPTION

Medical devices used to occlude a bodily lumen, organ, vessel, orcavity, as well as methods for making the devices and for treating asubject using the devices are provided in this disclosure. In general,the occlusion devices include one or more elongate members (hereinaftera “wire” or “wires”) combined with flexible membranous materials. Theocclusion devices utilize the wires and flexible membranous materials invarious configurations. The wires of the occlusion devices can definethe shape of the occlusion devices, and prevent or inhibit migration ofthe occlusion devices from a desired bodily location. The flexiblemembranous materials of the occlusion devices may be treated to enhance,for example, their thrombogenicity and epithelialization properties.

With reference to FIG. 1, a wire 10 of an example occlusion device isdepicted in a relaxed configuration 10 a and a low-profile deliveryconfiguration 10 b. In general, wire 10 is a component of an exampleocclusion device embodiment that also includes a flexible membranousmaterial (see, e.g., FIG. 3).

In some embodiments, the occlusion devices provided herein include oneor more such wires. The wires of the occlusion devices may exhibit, forexample, beneficial fatigue resistance and elastic properties. In someembodiments, the occlusion devices are constructed of one or more wiresthat have elastic and/or shape memory properties that allow the devicesto be configured in a low-profile configuration for transcatheterdelivery or thoracoscopic delivery, and to self-expand to an operativesize and configuration once positioned at a desired target site within abodily lumen, cavity, vessel, or organ.

The wires can comprise a variety of materials. The wires may beelastomeric, metallic, spring wires, shape memory alloy wires,super-elastic alloy wires, or combinations and sub-combinations thereof,to name a few general examples. In fact, any type of wire that issuitably biocompatible, flexible, and resilient can generally be usedfor the occlusion devices provided herein. For example, the wires cancomprise nitinol (NiTi), L605 steel, stainless steel, polymericmaterials, or any other appropriate biocompatible material, includingcombinations and sub-combinations of materials. In some embodiments,bioresorbable or bioabsorbable materials may be used, including, forexample, a bioresorbable or bioabsorbable polymer. In some suchembodiments, the wire may eventually dissolve, while leaving thrombus orcellular matter in its place. In some embodiments, the wire is fully orpartially coated to stimulate a biological reaction.

It should be clear that suitable wire materials include a variety ofmetallic shape memory materials and super-elastic alloys. Shape memoryrefers to the ability of a material to revert to an originally memorizedshape after plastic deformation by heating it above a criticaltemperature. Super-elasticity refers to the ability of a material todeform under strain to a very large degree, without having thisdeformation become permanent. For example, the shape memory materialsincluded in some embodiments are able to withstand a significant amountof bending and flexing and yet return to its original form withoutdeformation. Some metallic shape memory materials used in the occlusiondevices are described in U.S. Pat. Nos. 3,174,851; 3,351,463; and3,753,700, which are hereby incorporated by reference in theirentireties. Suitable shape memory materials include various stainlesssteels which have been physically, chemically, and otherwise treated toproduce high springiness, metal alloys such as cobalt chrome alloys(e.g., ELGILOY™), platinum/tungsten alloys, and the NiTi alloys.

The super-elastic properties of NiTi make it a suitable material for thewires of some embodiments of the occlusion devices provided herein. NiTiwire can be heat-set into a desired shape such that the NiTi wire willtend to self-expand into the desired shape when it is deployed from adelivery sheath into a bodily lumen, cavity, vessel or organ.

The wire can be treated in various ways to increase the radiopacity ofthe wire for enhanced radiographic visualization. In some embodiments,the wire is at least partially a drawn-filled type of NiTi containing adifferent material at the core, such as a material with enhancedradiopacity. In some embodiments, the wire has a radiopaque cladding orplating at least on portions of the wire.

In some embodiments, the diameter or thickness of the wires are about0.1 mm to 1.50 mm, but in other embodiments wires having smaller orlarger diameters are used. In some embodiments, the wires have adiameter of about 0.25 mm. It should be clear that wires of any suitablesize or diameter can be used.

In some embodiments, each of the one or more wires of the device havethe same diameter. In some embodiments, each of the one or more wires ofthe device have different diameters. In some embodiments, the one ormore wires have a consistent diameter along the length of the wire. Insome embodiments, one or more portions of the one or more wires arediametrically tapered or otherwise inconsistent in diameter. In someembodiments, the wires may be formed using a center-less grindingtechnique, such that the diameter of the wire varies along the length ofthe wire. The wires may have a round cross-sectional shape or may have across-sectional shape that is not round, such as a rectangle or otherpolygon. Examples of other cross-sectional shapes that the wires mayhave include a square, oval, rectangle, triangle, D-shape, trapezoid, orirregular cross-sectional shape formed by a braided or strandedconstruct. In some embodiments, the one or more wires of an occlusiondevice may include flat wires. In some embodiments, a combination ofvarious types of wires are used in an occlusion device. While in someembodiments the one or more wires of the device each have the samecross-sectional shape, in some embodiments, at least one wire has adifferent cross-sectional shape than one or more of the other wires.

In some embodiments, one or more wires of the occlusion devices providedherein may include one or more fixation elements (e.g., anchors, barbs,protrusions, and/or penetrating members). In some embodiments, suchfixation elements advantageously reduce or inhibit in situ migration ofthe occlusion devices after deployment to a target site within a bodilylumen, cavity, vessel or organ.

Referring to FIG. 1, wire 10 is shown in a relaxed configuration 10 aand a low-profile delivery configuration 10 b. The relaxed configuration10 a is the natural configuration that wire 10 seeks when it is notexposed to external forces. The low-profile delivery configuration 10 bis the configuration that wire 10 assumes when it is exposed to certainexternal forces, such as the equal and opposite stretching forces 5 and5′. While the low-profile delivery configuration 10 b is generallylinear, in some embodiments the configuration includes some undulations.

In some embodiments, a heat-set process is used to make wire 10 have therelaxed configuration 10 a. For example, in some embodiments wire 10 isa NiTi wire that has been heat-set into a helically coiled configurationcorresponding to relaxed configuration 10 a. In some implementations,the wire 10 is wound onto a suitable mandrel and then heated to heat-setthe wire 10 in a coiled configuration as substantially defined by themandrel geometry. While wire 10 is depicted in its relaxed configuration10 a as generally helical, as described further below in reference toFIGS. 6A-6F, a wide variety of coil configurations are envisioned. Insome embodiments, wire 10 is plastically deformed into the coiledrelaxed configuration 10 a. In some embodiments, wire 10 is molded intothe coiled relaxed configuration 10 a. In sum, any suitable method forconfiguring a wire in a coiled configuration can be utilized.

The delivery configuration 10 b can be attained by applying equal andopposite stretching forces 5 and 5′ to relaxed configuration 10 a. Wire10 is configured in a substantially linear shape while in thelow-profile delivery configuration 10 b. The delivery configuration 10 bis suitable for delivering the wire 10 to a desired target site in abodily lumen, cavity, vessel or organ using a delivery catheter orsheath. In general, the delivery configurations of the occlusion devicesprovided herein are low-profile configurations, so as to enable the useof small diameter delivery catheters or sheaths. To illustrate, as FIG.1 shows, the approximately linear low-profile delivery configuration 10b has a much smaller radial profile than the coiled relaxedconfiguration 10 a.

With reference to FIG. 2, an example occlusion device 20 includes a wire10 (not visible) covered by a membranous material 22. The exampleocclusion device 20 is depicted in a low-profile delivery configuration.That is, example occlusion device 20 is in a low-profile configuration(by virtue of stretching forces 5 and 5′) as used when deliveringexample occlusion device 20 via a delivery catheter or sheath. Uponemergence from the delivery catheter or sheath, the example occlusiondevice 20 would seek a relaxed configuration analogous to the coiledrelaxed configuration 10 a of FIG. 1 (or another configuration dependingon the type of occlusion device).

The flexible membranous materials used for the occlusion devicesprovided herein may have pores that are sized to substantially (or, insome embodiments completely) prevent the passage of bodily fluids andemboli through the membranous materials. In some embodiments, themembranous materials have a microporous structure that provides a tissueingrowth scaffold for durable occlusion and supplemental anchoringstrength of the occlusion devices in a bodily lumen, cavity, vessel ororgan. In some embodiments, the membranous materials are configured suchthat the inhibition of fluid passage through the membranous sheetmaterial is immediate and does not rely on a thrombotic process. In someembodiments, the membranous materials initiate a cascade of thrombosis,such that the final occlusive effect is attained by a combination ofinhibition of fluid passage by the membranous material and the blood'sown natural thrombetic process.

In general, the flexible membranous materials can comprise any suitablebiocompatible material. Suitable materials include, but are not limitedto, porous or non-porous synthetic polymers such as polyethylene,polypropylene, polyurethane, polyglycolic acid, polyesters, polyamides,polyesters such as polyethylene terephthalate, polyaramids,polyfluorocarbons such as fluorinated ethylene propylene (FEP),perfluorinated alkoxy (PFA), polytetrafluoroethylene (PTFE), andexpanded polytetrafluoroethylene (ePTFE), and their mixtures, blends andcopolymers. ePTFE materials are described in U.S. Pat. Nos. 3,953,566and 4,187,390 the entireties of which are hereby incorporated byreference. A suitable ePTFE polymeric sheet material is taught by U.S.Pat. No. 5,814,405, also hereby incorporated by reference in itsentirety. In some embodiments, the membranous materials arebioresorbable or bioabsorbable materials, such as bioresorbable orbioabsorbable polymers. In some embodiments, the membranous materialsare formed of a copolymer. In some embodiments, a first portion of themembranous material of an occlusion device is formed of a first materialand a second portion of the membranous sheet material of the device isformed of a second material. For example, the portion of the membranousmaterial that covers a wire of the device may be formed of a firstmaterial, and the remaining portions of the membranous sheet material ofthe device may be formed of a second material. In some embodiments,three or more types of membranous materials are used on a singleocclusion device.

Any suitable type of construction of the membranous material can be usedfor the occlusion devices provided herein. In some embodiments, themembranous material has a knitted construction. In some embodiments, themembranous material has a woven construction. In some embodiments, themembranous material has a mesh construction. In some embodiments, themembranous material has a film construction. In some embodiments, acombination of construction types are included in a single occlusiondevice. In some embodiments, multiple layers of dissimilar types ofmembranous materials and/or types of constructions are included in asingle occlusion device. In some embodiments, the membranous materialsinclude hairs or filaments of membranous material attached to thesurface of the membranous material. In some such embodiments, the hairsor filaments can increase the thrombogenicity of the membranousmaterial.

In some embodiments, the membranous materials are made in sheet or stripform. In some embodiments, the membranous materials are subsequentlywound, knitted or woven into a tube form. In some embodiments, themembranous materials are made in filament or thread form, and aresubsequently wound, knitted or woven into a sheet, strip or tube form.In some embodiments, the membranous materials are extruded as a sheet,strip, or tube form.

Some embodiments of the membranous materials are made by a spinningprocess. Some embodiments of spun membranous materials are made in sheetform. Some embodiments of spun membranous materials are made in tubeform, for example by spinning materials onto a mandrel. Various spinningprocesses can be used, including: wet spinning, dry spinning, meltspinning, extrusion spinning, direct spinning, gel spinning, andelectro-spinning, to name a few examples. In some embodiments, spinningprocesses provide membranous materials that include micro or nanofilaments.

In some embodiments, the membranous materials used in the occlusiondevices provided herein are modified by one or more chemical or physicalprocesses that enhance certain properties of the membranous materials.For example, in some embodiments, a hydrophilic coating is applied tothe membranous sheet materials to improve the wettability and echotranslucency of the membranous materials. In some embodiments themembranous materials are modified with chemical moieties that promoteone or more of endothelial cell attachment, endothelial cell migration,endothelial cell proliferation, and resistance to or promotion ofthrombosis. In some embodiments the membranous materials are modifiedwith one or more covalently attached drug substances (e.g., heparin,antibiotics, and the like) or impregnated with the one or more drugsubstances. The drug substances can be released in situ to promote woundhealing, reduce tissue inflammation, reduce or inhibit infections, andto promote various other therapeutic treatments and outcomes. In someembodiments the drug substance is a corticosteroid, a human growthfactor, an anti-mitotic agent, an antithrombotic agent, a stem cellmaterial, or dexamethasone sodium phosphate, to name some examples.Coatings and treatments may be applied before or after the membranousmaterial is affixed or disposed on the wire of the occlusion devices.Additionally, one or both sides of the membranous material may becoated. In some embodiments, certain coatings and/or treatments areapplied to the membranous material located on some portions of anocclusion device, and other coatings and/or treatments are applied tothe membranous material located on other portions of the occlusiondevices. In some embodiments, a combination of multiple coatings and/ortreatments are applied to the membranous materials. In some embodiments,certain portions of the device are left uncoated and/or untreated.

In some embodiments, the membranous materials used for the occlusiondevices herein are an elastomeric film material. That is, in someembodiments the membranous sheet materials can stretch and rebound toaccommodate the movement of the wires during reconfiguration of theocclusion devices, such as between the low-profile and the relaxedconfigurations. Such elasticity of the membranous materials can, in someembodiments, advantageously facilitate the reconfiguration of theocclusion devices without ancillary stress relief measures (such asincisions to the membranous material).

Still referring to FIG. 2, the membranous material 22 is applied to thewire 10 of the example occlusion device 20. In some embodiments, themembranous material 22 is applied to the wire 10 so that the membranousmaterial 22 creates a wire sleeve portion and a fringe 26 portion. Forexample, in some embodiments membranous material 22 is an elongate stripof material that is folded around the wire 10 to form the wire sleeve24, and the length-wise free ends of the strip are affixed to each otherto form the fringe 26. In some embodiments, the free ends of themembranous material 22 are affixed to each other using a fluorinatedethylene propylene (FEP) coating or film. In some embodiments, the freeends of the membranous material 22 are affixed to each other bystitching, welding/bonding, using various biocompatible adhesives, or byother suitable methods or a combination of methods. By folding the stripof membranous material 22 over the wire 10, the wire 10 can be fully orpartially covered by the membranous material 22. In some embodiments, aportion of the wire 10 can be exposed, i.e., a portion of the wire 10may not be covered by membranous material 22. For example, in someembodiments, the ends of the wire 10 are exposed.

In some embodiments, the membranous material 22 is applied to the wire10 by winding it around the wire 10. In some embodiments the diameter ofthe wound membranous material 22 is greater than the diameter of thewire 10 so that a fringe 26 can be formed. The fringe 26 can be formedby flattening the excess membranous material (material that remainsafter covering the wire) and affixing the flattened layers to eachother.

In some embodiments, the wire 10 and the fringe 26 are about the samelength (with the length being measured along the axis of the wire 10).In some embodiments, the fringe 26 extends past the ends of the wire 10so that the fringe 26 is longer than the wire 10. In some embodiments,the fringe 26 extends past the wire 10 on just one end of the wire 10.In some embodiments, the fringe 26 extends past the wire 10 on both endsof the wire 10.

In some embodiments, the wire 10 is not located along an edge of themembranous material 22. In some embodiments, the wire 10 is positionedabout in the middle of one or more strips of membranous material 22. Insome such embodiments, two or more fringe 26 portions are created—withthe wire 10 in between the fringe portions. While in some embodiments,the two or more fringe 26 portions have individual fringes 28 ofapproximately the same length, in some embodiments the two or morefringe 26 portions have individual fringes 28 of different lengths.

In some embodiments, the wire 10 is positioned off-center on (orbetween) one or more strips of membranous material 22 (but not at anedge). In some such embodiments, two or more fringe 26 portions withunequal transverse lengths are formed. In some embodiments, the wire 10is positioned on or between layers of membranous strips and the wire 10has a pattern that is not substantially linear. In some suchembodiments, two or more fringe 26 portions with variable and unequallengths are formed.

In some embodiments, the wire 10 has an adhesive coating to assist inthe application of the membranous material 22 to the wire 10, and toaffix the wire 10 to the membranous material 22. For example, in someembodiments the adhesive on the wire 10 is FEP, applied by a powdercoating process. In some embodiments, other biocompatible adhesives areused on the wire 10 in addition to or in place of FEP. The adhesive onthe wire 10 can cover the entire wire 10, or be in certain discretelocations on the wire 10.

In some embodiments, the membranous material 22 has adhesive properties.In some embodiments, a FEP coating or FEP film layer is applied to allor portions of the membranous material 22. In some embodiments, theadhesives are heat-activated. In some embodiments, various otherbiocompatible adhesives are incorporated within or on the surface of themembranous material 22. The adhesives can assist in attaching themembranous material 22 to the wire 10, as well as in adhering layers ofthe membranous material 22 to each other.

In addition to or instead of adhesives, any other suitable method foraffixing the wire 10 to the membranous material 22 can be used. Forexample, in some embodiments, the wire 10 is affixed to the membranousmaterial 22 using stitching. In some embodiments, the wire 10 has atextured surface, or textured surface portions, to create a grip betweenthe wire 10 and the membranous material 22. In some embodiments, thewire 10 has barbs or protrusions that penetrate the membranous material22 to affix the two together. In some embodiments, the wire 10 hasportions with a larger cross-sectional profile to create an interferencefit between the wire 10 and the sleeve 24 at certain locations. In someembodiments, the fit between the entire length of the wire 10 and thesleeve 24 is an interference fit. In some embodiments, the fit betweenthe entire length of the wire 10 and the wire sleeve 24 is aline-to-line fit.

A variety of other relationships between the wire 10 and the membranousmaterial 22 are also envisioned. For example, in some embodiments thedimensional fit between the wire 10 and the wire sleeve 24 of themembranous material 22 is a slip fit along the entire length of the wire10. In some embodiments, the wire 10 is not affixed to the membranousmaterial 22. In some embodiments, ends of the wire 10 are doubled-overand crimped to pinch and capture the membranous material 22.Alternatively, the membranous material 22 can extend beyond the end ofwire 10.

In some embodiments, the wire 10 is affixed to the membranous material22 by weaving the wire 10 through the membranous material 22. In somesuch embodiments, one or more layers of membranous sheet material 22 canbe included.

In some embodiments of the occlusion devices provided herein, one ormore radiopaque markers are included. The radiopaque markers can assistwith the radiographic visualization of the occlusion devices—which canbe beneficial during the implantation procedure. In some embodiments,the radiopaque markers are affixed at one or more locations on themembranous material. In some embodiments, the radiopaque markers areintegral portions of the membranous material. In some embodiments, theradiopaque markers are affixed at one or more locations on the one ormore wires. In some embodiments, the radiopaque markers are integralportions of the one or more wires. In some embodiments, the radiopaquemarkers are located at one or more locations on both the membranoussheet and the one or more wires. In some embodiments, the membranousmaterial is wetted with contrast solution prior to deployment to provideenhanced radiopacity during the deployment procedure.

In some embodiments, the fringe 26 portion(s) are initially a materialthat is non-integral to the membranous material elsewhere on anocclusion device (e.g., sleeve 24). In some such embodiments, the fringe26 can be, for example, affixed to the other membranous material as astep in the process of manufacturing an occlusion device. The fringe 26can be affixed to the membranous material using any suitable method suchas by using adhesives, stitching, welding, bonding, and the like. Insome such embodiments, the fringe 26 can be a dissimilar material (incomparison to the membranous material elsewhere on the occlusiondevice). In some embodiments, the material of the fringe 26 can beselected to provide desirable properties and features particularlysuited for individual fringes 28, whereas the membranous materialelsewhere on the device can be selected to provide properties andfeatures particularly suited for those locations. In some embodiments,the individual fringes 28 are made to be stiffer than the membranousmaterial used elsewhere on the device (to name one example). In someembodiments, non-integral membranous material is the same type ofmaterial as used elsewhere on the occlusion device 20.

Still referring to FIG. 2, individual fringes 28 can be formed byincising or cutting the fringe 26 portion(s) of the membranous material22 (as represented by the transverse cut-lines projecting from the wiresleeve 24). The cuts to the fringe 26 create multiple individual fringes28 of membranous material. In some embodiments, the fringe 26 cuts aremade approximately in a radial or orthogonal direction in relation tothe wire 10. In some embodiments, the fringe 26 cuts are made atnon-orthogonal angles in relation to the wire 10. In some embodiments, acombination of orthogonal and non-orthogonal cuts (in relation to thewire 10) are used. Therefore, in some embodiments the individual fringes28 are generally rectangular-shaped. In some embodiments, the individualfringes 28 are triangular or shaped like trapezoids. In someembodiments, the individual fringes 28 are irregularly shaped. In someembodiments, the individual fringes 28 of an occlusion device are avariety of such shapes and irregular shapes.

With reference to FIG. 3, the example occlusion device 20 is illustratedin a low-profile delivery configuration 20 a and a relaxed configuration20 b (depending on presence or absence of stretch forces 5 and 5′). Themultiple individual fringes 28 are now distinctly visible. Theindividual fringes 28 can also be considered as membranous strips,strands, ribbons, fingers, filaments, projections, bristles, free ends,frayed portions, hairs, and the like. In some embodiments, theindividual fringes 28 perform various beneficial functions for occlusiondevices. For example, when the occlusion device 20 is implanted in abodily lumen, cavity, vessel, or organ, the individual fringes 28 mayprovide fluid flow obstructions, cavity filler material, tissue ingrowthscaffolding, thrombogenicity elements, and the like. In addition, insome embodiments the individual fringes 28 provide a stress relieffunction that is beneficial when the wire is transitioned between itslow-profile delivery and its relaxed configurations. That is, theindividual fringes 28 can tend to reduce some external forces that themembranous sheet 22 may otherwise exert on the wire 10 as the wirechanges shapes. When occlusion device 20 is implanted in a bodily lumen,cavity, vessel, or organ, occlusion device 20 approximately takes on theconfiguration of relaxed configuration 20 b.

The individual fringes of the occlusion devices provided herein can haveany suitable length. In some embodiments, the fringes are about 2.50 mmto 12.70 mm long, but in other embodiments fringes with shorter orlonger lengths are used. For example, embodiments using spun membranousmaterials can include fringes, hairs, or filaments in the nano range. Itshould be understood that fringes of any suitable length are envisionedwithin the scope of this document. In some embodiments, the fringes havea substantially consistent length on the entire occlusion device. Insome embodiments, the fringes have variable lengths at differentlocations on the occlusion device. For example, in some embodiments thefringes are longer near the middle of the occlusion device than at theends of the occlusion device. In some embodiments the fringes areshorter near the middle of the occlusion device than at the ends of theocclusion device. In some embodiments, the lengths of the fringes varyapproximately according to a pattern (e.g., a sinusoidal wave or otherpattern). In some embodiments, the lengths of the fringes are randomlyvariable.

Individual fringes of the occlusion devices provided herein can beformed to have a variety of widths or diameters. In some embodiments,the widths or diameters of the fringes are about 0.50 mm to 2.50 mm, butin other embodiments fringes having wider or narrower widths ordiameters are used. It should be understood that fringes of any suitablewidth or diameter are envisioned within the scope of this document. Insome embodiments, the fringes have a substantially consistent width ordiameter on the entire occlusion device. In some embodiments, thefringes have variable widths or diameters at different locations on theocclusion device. For example, in some embodiments the fringes are widernear the middle of the length of the occlusion device than at the endsof the occlusion device. In some embodiments, the fringes are narrowernear the middle of the length of the occlusion device than at the endsof the occlusion device. In some embodiments, the widths or diameters ofthe fringes vary approximately according to a pattern along the lengthof the wire. In some embodiments, the widths or diameters of the fringesare randomly variable.

With reference to FIG. 4, an example occlusion device 40 is illustratedin its delivery configuration 40 a and its relaxed configuration 40 b.The example occlusion device 40 includes a membranous tube 42 and one ormore wires 10. The natural relaxed (or shape-memory) configuration ofwire 10 is a coiled configuration (see, e.g., FIGS. 6A-6F). Therefore,for occlusion device 40 to be in the delivery configuration 40 arequires the application of external force(s), such as stretching forces5 and 5′. The elimination or substantial reduction of stretching forces5 and 5′ allows the occlusion device 40 to coil into its relaxedconfiguration 40 b. Configuration 40 b is approximately theconfiguration that the occlusion device 40 will assume when it isimplanted in a bodily lumen, cavity, vessel, or organ.

The materials and methods of construction of occlusion device 40 aregenerally analogous to the materials and methods of construction ofocclusion device 20 described above. For example, membranous tube 42 canbe constructed using any of the materials, material treatments, andmanufacturing methods described above in regard to membranous materialsand tubes. In addition, wire 10 can be constructed using any of thematerials, material treatments, and manufacturing methods describedabove. Further, the membranous tube 42 and wire 10 can be affixed toeach other using any of the methods described above for affixing amembranous sheet to a wire.

However, differences exist between occlusion device 40 illustrated inFIG. 4 and occlusion device 20 described above. For example, in someembodiments the diametric size difference between the membranous tube 42and wire 10 is greater than the diametric size difference between sleeve24 and the wire 10 of occlusion device 20. In some embodiments, the sizedifference between the membranous tube 42 and wire 10 allows the wire 10to take the form of a helix within the membranous tube 42 when theocclusion device 40 is in the delivery configuration 40 a. In someembodiments, the wire 10 takes non-linear forms other than a helixwithin the membranous tube 42, when the occlusion device 40 is in thedelivery configuration 40 a. In some embodiments, the wire 10 issubstantially linear within the membranous tube 42.

Further, in some embodiments example occlusion device 40 does notinclude fringes like occlusion device 20. Rather, the membranous tube 42becomes bunched or gathered together when the occlusion device 40 isconfigured in its relaxed configuration 40 b. The membranous tube 42 inits bunched together arrangement can provide the occlusive properties aswell as other properties that are desirable for an occlusion device.

With reference to FIG. 5, another example occlusion device 50 isillustrated in its delivery configuration 50 a and its relaxedconfiguration 50 b. The example occlusion device 50 includes amembranous tube 52 and one or more wires 10. The relaxed (orshape-memory) configuration of wire 10 is a coiled configuration (see,e.g., FIGS. 6A-6F). Therefore, for occlusion device 50 to be in thedelivery configuration 50 a requires the application of externalforce(s), such as stretching forces 5 and 5′. The elimination orreduction of stretching forces 5 and 5′ allows the occlusion device 50to coil into its relaxed configuration 50 b. Configuration 50 b isapproximately the configuration that the occlusion device 50 will assumewhen it is implanted in a bodily lumen, cavity, vessel, or organ.

Example occlusion device 50 includes the features of example occlusiondevice 40 described above. In addition, occlusion device 50 includesindividual fringes 58. In general, the individual fringes 58 can beconstructed and can include the features described above in reference tofringes 28.

In some embodiments, the individual fringes 58 can be formed by makingmultiple transverse cuts to the membranous tube 52 (fringe cut-lines arerepresented by the substantially radial lines shown in deliveryconfiguration 50 a). In some embodiments, individual cuts are not madefully around the circumference of the membranous tube 52. That is, anindividual cut does not fully sever a portion of the membranous tube 52so as to create multiple tubes. For example, in some embodiments theportions of the membranous tubes 52 adjacent to the wire 10 are not cut.

When occlusion device 50 is allowed to assume its relaxed configuration50 a, the individual fringes 58 can project from the coiled wire 10 soas to create a larger profile as compared to similar occlusion deviceswithout fringes 58. The larger profile can be advantageous for certainimplementations of an occlusion device.

FIGS. 6A-6F illustrate example wire coil shape embodiments. The coilshapes shown are approximately in their relaxed configurations. However,in some examples the coils are enlarged or elongated to assist with thevisualization of the configuration of the coil shape. The example coilshapes provided have shapes and properties that can be mixed and matchedin any combination to provide the desired shape and properties of thewires for various embodiments of the occlusion devices provided herein.

FIG. 6A illustrates a generally helical coil 60 that is similar to therelaxed configuration 10 a of FIG. 1. The generally helical coil 60 ismade from wire 61. The generally helical coil 60 includes ends 62 and62′. The ends 62 and 62′ are made by doubling over the wire 61. This hasthe effect of making ends 62 and 62′ more bluntly-shaped than the ends62 and 62′ would be if the wire was not doubled over. Such blunt endsare desirable in some occlusion device embodiments. In some embodiments,the ends of the wire can be made blunt by other techniques, such as byadding bulbous tips to the ends of the wire.

FIG. 6B illustrates a triangular coil 63. In some embodiments, the coilssuch as triangular coil 63 (and the others described herein) can beformed by winding the wire 61 onto a mandrel that defines the generalshape of the coil being made. For example, triangular coil 63 can beformed by wrapping the wire 61 in a triangular pattern on a suitablemandrel. In some embodiments, a super-elastic shape memory alloy wirecan be used, and the wire can be heat-set into the pattern it acquiredas a result of being wound onto a mandrel.

FIG. 6C illustrates a double coil 65. Double coil 65 includes wires 61and 64 that are wound on the same axis, in the same direction, and usingthe same pitch. In the embodiment shown, the wires 61 and 64 operate inconjunction with each other like two strands of a stranded wire. Whiledouble coil 65 has side-by-side wires 61 and 64, in some embodiments thewires can be twisted together or otherwise entangled with each other. Insome embodiments, the wires 61 and 64 can be incongruent, have differentpitches, or be on different axes. In some embodiments, such multiplestranded constructions can provide a coil with enhanced capabilities tobe elastically deformed, while also providing a stronger bias to seekthe relaxed configuration as compared to a single wire. In someembodiments, more than two wires are used in a coil embodiment.

FIG. 6D illustrates another coil 66 that is made of more than one wire.Coil 66 includes wires 61 and 64. In this embodiment, one wire is woundusing a right-handed helix and the other wire is wound using aleft-handed helix. Both are wound on the same axis. In some embodiments,the wires can be wound on different axes. In some embodiments, the wires61 and/or 64 comprise multiple stranded wires such as side-by-side wiresas shown.

FIG. 6E illustrates a randomized coil 67. In this embodiment, the turnsof wire 61 are wound at various coil diameters, axes, pitches, and soon. This randomized configuration can provide enhanced occlusion in someimplementations.

FIG. 6F illustrates a conical coil 68. In this embodiment, the wire 61is wound with an increasingly larger outer diameter for each coil turn,while on the same axis. This conical coil 68 configuration can provideenhanced occlusion at the center area of the occlusion device in someimplementations.

With reference to FIG. 7, a wire frame 70 of an example cup-shapedoccluder embodiment is depicted in a relaxed configuration 70 a and adelivery configuration 70 b (again depending on presence or absence ofstretch forces 5 and 5′). In general, wire frame 70 is a component of anexample occlusion device embodiment that also includes a membranousmaterial (see, e.g., FIGS. 8 and 9).

In the illustrated embodiment the wire frame 70 includes two (2)portions. The first portion is a cup frame 72. The second portion is acoil portion 74 (shown in a relaxed configuration 74 a and a low-profileconfiguration 74 b). In some embodiments, the wire frame 70 is made of asingle wire 71. In some embodiments, the wire frame 70 is made of two ormore wires. When two or more wires are used, they may or may not becoupled together. In some embodiments, the wire frame includes three ormore portions. The wire 71 has the properties and features of the wiresdescribed above.

In some embodiments, the wire frame 70 includes the cup frame 72portion, but no coil portion 74 is included. In some such embodiments,the occluder device embodiment includes a membranous cup portion anddoes not include an additional membranous occluder portion (i.e.,portion 74 of FIG. 8 and portion 96 of FIG. 9 is not included).

The cup frame 72 is generally shaped like a wire-framed open cylinder.In some embodiments, the cup frame 72 can be formed by bending a wire 71in an undulating or serpentine fashion (e.g., a generally sinusoidalpattern, U-shaped, V-shaped, ovaloid-shaped, and the like) around acylindrical mandrel. An open lumen in the interior of the wire-framedcylinder is created, and the ends of the wire-framed cylinder are open.

The cup frame 72 is formed so that it can be radially compressed to alow-profile configuration for placement in a delivery catheter or sheath(as will be described further below in reference to FIGS. 10A-10D).

The coil portion 74 of wire frame 70 generally includes the propertiesand features of wires 10, 10, 10, and 61 described above. In someembodiments, coil portion 74 is made from a wire 71 that is also used toform the cup frame 72.

With reference to FIG. 8, an example cup-shaped occlusion device 80includes a wire 71 and a membranous tube 82. The example cup-shapedocclusion device 80 is shown in a low-profile configuration 80 a and arelaxed configuration 80 b (again depending on presence or absence ofstretch forces 5 and 5′).

Wire 71 of example cup-shaped occlusion device 80 can be configured, forexample, as the wire frame 70 described in reference to FIG. 7. That is,in some embodiments wire 71 can have a cup frame portion 72 and a coilportion 74. A membranous tube 82 can be affixed to wire 71, continuouslyor intermittently, using any of the variety of methods described above(e.g., adhesives, stitching, friction, weaving, interference, etc.).

The membranous tube 82 can be constructed using any of the materials,treatments, and manufacturing methods described above in regard tomembranous materials. For example, in some embodiments, the membranoustube 82 is an extruded polymeric film tube. In some embodiments, themembranous tube 82 is a helically-wound strip of membranous material. Insome embodiments, the membranous tube 82 has a woven or knittedconstruction.

Membranous tube 82 includes a distal end 83 and a proximal end 84. Theproximal end 84 is a closed end of the membranous tube 82. In someembodiments, the distal end 83 is an open end of the membranous tube 82.In some embodiments, the distal end 83 is a closed end of the membranoustube 82.

A membranous cup portion 85 is located at the proximal end 84. In someembodiments, the membranous cup portion 85 can be formed by simplygathering and cinching the membranous tube 82 at the proximal end 84. Aclip device, purse string sutures, or similar methods can be used tocinch closed the membranous tube 82 to create the cup portion 85. Insome embodiments, the membranous cup portion 85 can be sewn or coheredto create a conical, semispherical, cylindrical, or other similarthree-dimensional cup-like shape.

As will be described further in reference to FIG. 10D, when the examplecup-shaped occlusion device 80 is implanted at a desired target sitewithin a bodily lumen, cavity, vessel, or organ (for example, to treatendoleaks), the membranous cup portion 85 will be everted within theinterior of cup frame 72. In that configuration, the cup portion 85 willbe positioned to occlude or reduce the passage of fluids through thevessel or cavity.

With reference to FIG. 9, an example cup-shaped occlusion device 90includes a wire 71 and a membranous tube 92. The membranous tube 92includes a distal end 93 and a proximal end 94. The example cup-shapedocclusion device 90 is shown in a low-profile configuration 90 a and arelaxed configuration 90 b (again depending on presence or absence ofstretch forces 5 and 5′).

Example cup-shaped occlusion device 90 includes the properties andfeatures of the example cup-shaped occlusion device 80 described above.In addition, example cup-shaped occlusion device 90 includes individualfringes 98.

In some embodiments the individual fringes 98 can be formed by makingmultiple transverse cuts to the membranous tube 92 in the distal portion96. Fringe cut-lines are represented by the substantially radial linesshown in the low-profile configuration 90 a. As with the embodimentdescribed above in reference to FIG. 5, the individual cuts are not madefully around the circumference of the membranous tube 92. That is, anindividual cut does not fully sever a portion of the membranous tube 92so as to create multiple tubes. For example, in some embodiments theportions of the membranous tube 92 that are adjacent to the wire 71 arenot cut. In some embodiments, the portions of the membranous tube 92that (i) covers the wire cup frame and (ii) forms the membranous cupportion 95 are also not cut to create fringes.

When occlusion device 90 is allowed to assume its relaxed configuration90 a, the individual fringes 98 can project from the distal portion 96so as to create a larger profile as compared to similar occlusiondevices without fringes 98. The larger profile can be advantageous forcertain implementations that are suited to having a higher occlusiveand/or thrombogenicity properties.

FIGS. 10A-10D provide a series of illustrations to depict an examplemethod of deploying an example cup-shaped occlusion device 90 within avessel 110 using an example deployment system 100. The vessel 110 has afluid (e.g., blood) flowing through it in a direction indicated by arrow120, i.e., arrow 120 points in a distal direction. Therefore, thedirection opposite of arrow 120 is the proximal direction. The examplecup-shaped occlusion device 90 is the occlusion device described inreference to FIG. 9 above. However, other types of occlusion devices canbe deployed using the methods provided here (or by using minorvariations of the methods). The example delivery system 100 generallyincludes a delivery sheath (or catheter) 102 and a pusher catheter 104.

In FIG. 10A, the example deployment system 100 containing the examplecup-shaped occlusion device 90 is depicted as approaching animplantation site within the vessel 110. The deployment system 100includes a delivery catheter or sheath 102. In some embodiments, thedelivery sheath 102 is a tube that is used to constrain an occlusiondevice in its low-profile delivery configuration, and to percutaneouslydeliver the occlusion device to a target deployment site within a bodilycavity or vessel. The tubular delivery sheath 102 can have a circularcross-section or another cross-sectional shape, such as ovular or othersuitable shapes. A proximal end of the delivery sheath 102 can beattached to a deployment actuator (e.g., a handheld deployment actuatoror a non-handheld deployment actuator) that can be operated by aclinician operator. In some embodiments, the deployment actuatorprovides one or more controls that permit a clinical operator to controlone or more aspects of the delivery sheath 102. In some embodiments, thedelivery sheath 102 is a steerable delivery sheath. In some embodiments,at least the distal end portion of the delivery sheath 102 is steerable.In some embodiments, a guidewire is installed in the patient first, andthe delivery sheath 102 is installed over the guidewire. The deliverysheath 102 can have one lumen or multiple (e.g., two or more) lumens. Insome embodiments, radiopaque markers are included on portions of thedelivery sheath 102 (e.g., the tip) to assist with radiographicvisualization of the delivery sheath 102 during the installation of thedelivery sheath 102 into the body of a patient.

The delivery sheath 102 contains the example cup-shaped occlusion device90. At this stage of the deployment process the cup-shaped occlusiondevice 90 is in a low-profile delivery configuration so as to fit withina lumen of the delivery sheath 102. To achieve the low-profile deliveryconfiguration, the coil portion 74 is stretched axially to elongate thecoil and to reduce its radial profile, and the cup frame 72 is radiallycompressed to reduce its radial profile. Once the occlusion device 90resides within the delivery sheath 102, the delivery sheath 102 exertscontainment forces on the occlusion device 90 to retain the occlusiondevice 90 in its low-profile delivery configuration.

The example deployment system 100 also includes a pusher catheter 104.In some embodiments, the pusher catheter 104 is a flexible polymerictubular component. The pusher catheter 104 is located within a lumen ofthe delivery sheath 102. In some embodiments, the distal end of thepusher catheter 104 is releasably coupled to the occlusion device 90. Insome embodiments, the proximal end of the pusher catheter 104 is coupledto a deployment actuator, and the deployment actuator provides one ormore controls that permit a clinical operator to control one or moreaspects of the pusher catheter 104. In other deployment systemembodiments, other types of devices for constraining and remotelydeploying an occlusion device (other than a pusher catheter) can beused.

In some embodiments, the pusher catheter 104 is releasably coupled to aconnector element of the occlusion device 90. In some embodiments, thepusher catheter 104 is releasably coupled to the membranous sheet orwire portions of the occlusion device 90. In some embodiments, thepusher catheter 104 contains a looped suture, clip, clamp, or similarstructure that releasably couples the pusher catheter 104 to theocclusion device 90. In some embodiments, the looped suture or similarstructure is radiopaque.

In some embodiments, the pusher catheter 104 includes two or more lumensthrough which the looped suture 106 passes. That is, one portion of thelooped suture 106 can pass through a first lumen in the pusher catheter104 and a second portion of the looped suture 106 can pass through asecond lumen in the pusher catheter 104. In some embodiments, the loopedsuture 106 can pass through a single lumen in the pusher catheter 104.In some embodiments, the looped suture 106 is a strand of suturematerial that is used to releasably couple the pusher catheter 104 tothe occlusion device 90 by tethering them together. For example, thepusher catheter 90 of FIG. 10A illustrates a looped suture 106 attachedto the membranous sheet of the occlusion device 90. In some embodiments,the looped suture 106 is a single length of suture material with bothends of the looped suture 106 located at the proximal end of thedeployment system 100, such as at or near the deployment actuatorcoupled to the deployment system 100. In some embodiments, the loopedsuture 106 is routed from the proximal end of the deployment system 100,through a first lumen in the pusher catheter 104, exiting the firstlumen at the distal end of the pusher catheter 104, coupling to themedical device, re-entering the distal end of the pusher catheter 104via a second lumen, and running back through the second lumen to theproximal end of the deployment system 100. The clinician operator cantug on the ends of the looped suture 106 to snug the pusher catheter 104to the occlusion device 90. When the pusher catheter 104 is snugged tothe occlusion device 90, movement of the pusher catheter 104 will tendto induce a corresponding movement of the occlusion device 90. In someembodiments, one or both ends of the looped suture 106 are coupled tothe deployment actuator, which may provide one or more controlspermitting the clinical operator to control one or more aspects of theocclusion device 90.

In FIG. 10B, the delivery sheath 102 has been partially pulled back(translated proximally) while the pusher catheter 104 has beenmaintained substantially stationary. This relative movement between thedelivery sheath 102 and the pusher catheter 104 has caused the distalportion 96 of the occlusion device 90 to emerge from the lumen of thedelivery sheath 102. With the containment forces of the delivery sheath102 on the distal portion 96 substantially removed, the distal portion96 is freed to self-expand to seek its relaxed configuration. In turn,the distal portion 96 can contract axially and expand radially as thewire in the distal portion 96 seeks its natural relaxed coiled shape. Inits relaxed state, distal portion 96 is radially expanded to entirely orpartially fill the lumen of vessel 110.

In some deployment method implementations, the pusher catheter 104 canbe pushed distally while the delivery sheath 102 is maintainedsubstantially stationary. That relative movement between the deliverysheath 102 and the pusher catheter 104 can cause the distal portion 96of the occlusion device 90 to emerge from the lumen of the deliverysheath 102, similarly to the method of pulling back the delivery sheath102 described above. In some deployment method implementations, acombination of the two methods are used.

In FIG. 10C, the delivery sheath 102 has been further pulled backproximally while the pusher catheter 104 has been maintainedsubstantially stationary. This relative movement between the deliverysheath 102 and the pusher catheter 104 has caused the entire occlusiondevice 90 to emerge from the lumen of the delivery sheath 102. With thecontainment forces of the delivery sheath 102 on the occlusion device 90removed, the cup frame 72 is freed to self-expand to seek its relaxedconfiguration. In turn, the cup frame 72 can expand radially as the wirein the cup frame 72 seeks its natural relaxed shape. In its relaxedstate, the cup frame 72 can radially expand to fully or partially becomeadjacent to the inner walls of vessel 110. The membranous cup portion 95of the occlusion device 90 is also emerged from the delivery sheath 102at this stage.

At this stage of the deployment process, the clinician operator canconfirm the desirability of the position of the occlusion device 90 inrelation to the surrounding bodily tissue. In some cases, clinicians usemagnetic resonance imaging (MRI) or x-ray fluoroscopy imaging tovisualize the positioning of the occlusion device 90. In general, theclinician may be interested in one or more of the position, location,orientation, anchoring strength, and the sealing properties of theocclusion device 90 in relation to the surrounding tissue. In someembodiments, radiopaque markers or jackets can be included on theocclusion device 90, such as on the wire and/or on the membranousmaterial. In some embodiments that include a radiopaque looped suture106, the adequacy of the fixation of the occlusion device 90 can beconfirmed by inducing slack in the looped suture 106 and usingradiography to visualize that the slack is maintained over a period oftime.

In some implementations, to simulate the likely position that theocclusion device 90 may take after being released from the looped suture106, the clinician operator may loosen, but not fully release, thelooped suture 106 from its hold on the occlusion device 90. That is, theclinician may induce some slack in the looped suture 106 so that it isnot tightly engaged with the occlusion device 90. Loosening the loopedsuture 106 may mitigate some of the positional influence that the loopedsuture 106 may be exerting on the occlusion device 90 as a result oftheir engagement. With the looped suture 106 loosened, the clinician canassess the positioning and anchorage strength of the occlusion device 90with respect to the surrounding tissue. If the clinician is notsatisfied with the positioning or anchorage strength of the occlusiondevice 90, the looped suture 106 can be retightened in order to restorethe ability to reposition the occlusion device 90 by manipulating thepusher catheter 104 and looped suture 106.

The clinician operator may manipulate the occlusion device 90 using thepusher catheter 104 for various purposes. The manipulation of the pushercatheter 104 can serve to reposition and/or seat the occlusion device 90to the tissue at the deployment site. In some embodiments, anchoringdevices (e.g., barbs, protrusions, etc.) are included on the occlusiondevice 90. In those embodiments, manipulation of the pusher catheter 104can help to embed the anchoring devices into or onto the surroundingtissue.

If the clinician is dissatisfied with the position or anchorage strengthof the occlusion device 90, the clinician can retrieve and re-containthe occlusion device 90 within a lumen of the delivery sheath 102. To doso, the clinician can, for example, advance the delivery sheath 102distally, while substantially maintaining the axial position of thepusher catheter 104 which is affixed to the occlusion device 90 by thelooped suture 106. After re-capturing the occlusion device 90 within thedelivery sheath 102, the clinician operator can repeat the process stepsdescribed above for deploying the occlusion device 90. In someembodiments, a common snare can also be used to assist in the recapturethe occlusion device 90.

When the clinician operator is satisfied with the positioning of theocclusion device 90, the clinician can release the occlusion device 90from the deployment system 100. For example, the clinician can removethe looped suture 106 from engagement with the occlusion device 90. Todisengage the looped suture 106 from the occlusion device 90, theclinician operator can release one end of the looped suture 106 and pullon the other end of the looped suture 106 to draw a suitable length ofthe looped suture 106 out from the pusher catheter 104. After drawingthe suitable length of the looped suture 106 from the pusher catheter104, the looped suture 106 will become disengaged from the occlusiondevice 90. At this stage, the occlusion device 90 has been fullydecoupled from the deployment system 100. In some embodiments, thelooped suture 106, or other device used to couple the pusher catheter104 to the occlusion device 90, may be detached from the pusher catheter104 at the time of deployment and allowed to flow with the fluid intothe everted membranous cup portion 95 for packing purposes.

In FIG. 10D, the occlusion device 90 is shown in its deployedconfiguration within vessel 110. The delivery system 100 has beenwithdrawn from the implantation site. The membranous cup portion 95 hastransitioned to an everted cup orientation. That is, the membranous cupportion 95 has moved distally to within the lumen defined by the cupframe 72 (cup frame 72 is not shown in this view so that the evertedmembranous cup portion 95 can be more clearly visualized). In thisorientation, the membranous cup portion 95 is well positioned to occludethe fluid that would tend to flow through vessel 110.

The transition of the membranous cup portion 95 to the everted cuporientation can take place in various manners. In some implementations,the membranous cup portion 95 will become everted as a result of thefluid pressures within the vessel 110. For example, since the flow invessel 110 is in the direction of arrow 120, the membranous cup portion95 may naturally become everted by the pressure exerted by the fluid.This can be analogized to the functioning of a windsock. As axial fluidflow continues into everted cup, it produces radial pressure sufficientto expand the cup to its fluid capacity. In some implementations, themembranous cup portion 95 will become everted as a result of an actionof the clinician operator. For example, the clinician may use the pushercatheter 104 to nudge the membranous cup portion 95 to the evertedorientation. In some implementations, a combination of such factors maycause the membranous cup portion 95 to become everted to within the cupframe 72.

The everted membranous cup portion 95 may have various volumetriccapacities. In some embodiments, the everted membranous cup portion 95has a capacity that does not fill the entire internal space defined bythe cup frame 72. In some embodiments, the everted membranous cupportion 95 may have a fluid capacity equivalent to or greater than thevolume within the internal space formed by the cup frame 72. In somesuch embodiments, the everted membranous cup portion 95 is designed toprevent the addition of substantial radial forces from the membranouscup portion 95 onto the cup frame 72. In some such embodiments, thefilling of the everted membranous cup portion 95 with fluid and theresulting radial expansion of the everted membranous cup portion 95 willpress it against the internal surface of the cup frame 72, and in someembodiments also against the walls of the vessel lumen, thereby aidingin preventing migration of the device. In some embodiments, themembranous cup portion 95 is designed to create only a limited amount ofradial force so that the potential for rupture of the bodily lumen,cavity, vessel, or organ is mitigated.

As described above, some embodiments of cup-shaped occluder devicesinclude a cup frame 72 portion, but no coil portion is included. In someembodiments, the occluder device embodiment includes a membranous cupportion but may not include an additional membranous occluder portion(i.e., portion 74 of FIG. 8 and portion 96 of FIG. 9 may not beincluded). In some such embodiments, it is evident that a longer evertedmembranous cup portion 95 whose distal end (when everted) extends pastthe distal end of the cup frame 72 may increase the surface contact ofthe everted membranous cup portion 95 with the vessel wall, therebyincreasing the migration resistance of the occlusion device. As such,the membranous cup portion 95 may be sized such that it extends 5, 10,15, 20, 25, 30, 35, 40 mm or more past the distal end of the cup frame72. In addition, the membranous cup portion 95 may be volumetricallysized so, when fully expanded, its diameter is slightly larger than theinner diameter of the cup frame 72. As such, the membranous cup portion95 will be able to bulge through the spaces between winds of the cupframe 72 to contact the wall surface of the vessel along all or at leasta portion of the length of the occlusion device.

The wire of occlusion device 90 may include one or more fixationelements (e.g., anchors, barbs, protrusions, and/or penetrating members)which engage the cup frame 72 with the wall of the vessel 110 to preventmigration of the occlusion device 90 after deployment within the vessel110. Likewise, in embodiments wherein the surface of the evertedmembranous cup portion 95 contacts the wall of the vessel, themembranous sheet material may include features to increase frictionbetween the cup surface and wall of the lumen. For example, in someembodiments a coating that imparts a rough surface texture can beapplied to the membranous sheet. Coatings, including granules ofpolymeric materials, are known in the art and may be used to impart atextured surface to the membranous sheet material to impart increasedfrictional properties to prevent movement of the occlusion devicesprovided herein. For example, the polymers heat-treated withpolyfluorocarbon granules as described in co-owned and pending U.S.Publication No. 2012/0064273 entitled “Porous Article”, filed Sep. 10,2010 and hereby incorporated by reference in its entirety, are suitablefor use with the membranous cup portion 95.

As discussed above, to facilitate in vivo placement of the occlusiondevices, a radiopaque material may be incorporated to allow fordetection of the position of the device within a bodily lumen, cavity,vessel, or organ. A number of radiopaque materials and coatings are wellknown in the art which may be incorporated onto the surface of thedevice or otherwise integrated into the device. By way of illustration,such materials include gold, platinum, platinum-tungsten, palladium,platinum-iridium, rhodium, tantalum, or alloys or composites thereof.The radiopaque materials may be incorporated over the entire device orin discrete regions, and in any number of patterns, to allow forradiographic detection. For example, in some embodiments at least thedistal end of the wire includes radiopaque materials.

Upon deployment into a bodily lumen, cavity, vessel, or organ theocclusion devices provided herein obstruct fluid flow to occlude thebodily lumen, cavity, vessel, or organ. In some embodiments, theocclusion devices also promote one or more of thrombus formation andendothelialization.

FIG. 11 depicts an example process 200 for manufacturing occlusiondevices such as the coil occlusion devices described above in referenceto FIGS. 1-6F. The materials and manufacturing methods described abovein reference to the occlusion devices are applicable to process 200. Thedescription of process 200 includes concise statements regarding itsoperational steps which can assist the reader to correlate the steps ofprocess 200 to relevant subject matter from above.

The process 200 begins at operation 210 where at least one shape memorywire is provided. As described above, the wire can comprise any suitablebiocompatible material, such as metallic or polymeric materials. In someembodiments, the wire is a super-elastic alloy material.

At operation 220, the wire can be formed into a coil shape. In someembodiments, the wire is wound onto a mandrel to form the coil shape. Insome embodiments, the wire that is wound into a coil shape is heat-setso that the wire memorizes the coiled shape. In some embodiments, thewire is plastically deformed into the coil shape. A variety of coilshapes can be used. FIGS. 6A-6F provide some illustrative examples.

At operation 230 the coil is elongated. In some embodiments, the coil iselongated by stretching the coil. That is, the coil can be elongated bypulling apart or displacing the ends of the coil in opposite directions.In some embodiments, the elongated coil is substantially linear. In someembodiments, the elongated coil has an undulating shape that isreminiscent of the coiled shape of the wire. The elongated coil has alength that is greater than the coil prior to elongation. The elongatedcoil has a diameter that is less than the overall diameter of the coilprior to elongation.

At operation 240, a membranous material is affixed to the elongatedcoil. In some embodiments, the membranous material is a strip ofmaterial. In some embodiments, the membranous material is a strip thatis wound onto or folded over the elongated coil. In some embodiments,the membranous material is a tube that surrounds the elongated coil. Insome embodiments, the tube is made by winding a membranous strip. Insome embodiments, the tube is knitted, woven, or extruded. In someembodiments, the membranous material is affixed to the elongated coil byan adhesive, by friction, by an interference fit, or by weaving theelongated coil within the membranous material, to name some examples. Insome embodiments, the membranous material is affixed to the elongatedcoil so as to provide a fringe portion, i.e., a portion of membranousmaterial that is not in direct contact with the elongated coil.

At operation 250, optionally, fringes of membranous material can beformed or added on the occlusion device. In some embodiments, thefringes are formed by incising the membranous material. In someembodiments, the fringes are an additional portion of membranousmaterial that is affixed to the occlusion device.

At operation 260, the elongated coil with the affixed membranousmaterial can be allowed to recoil to a contracted coil shape. In someembodiments, the elongated coil will be biased to contract to a coiledshape as a result of operation 220. In some embodiments, this operationwill cause the membranous material that is affixed to the elongated coilto also become be rearranged, i.e., the membranous material will becomebunched up or compressed into a wad.

FIG. 12 depicts an example process 300 for manufacturing occlusiondevices such as the cup-shaped occlusion devices described above inreference to FIGS. 8 and 9. The materials and manufacturing methodsdescribed above in reference to the occlusion devices are applicable toprocess 300. The description of process 300 includes concise statementsregarding its operational steps which can assist the reader to correlatethe steps of process 300 to relevant subject matter from above.

The process 300 begins at operation 310 where one or more shape memorywires are provided. As described above, the wire can comprise anysuitable biocompatible material such as metallic or polymeric materials.In some embodiments, the wire is a super-elastic alloy material.

At operation 320, the one or more wires are formed into a cup frame. Insome embodiments, the cup frame is a wire-framed open cylinder. In someembodiments, the cup frame can be formed by bending the wire in anundulating or serpentine fashion (e.g., a generally sinusoidal pattern,U-shaped, V-shaped, ovaloid-shaped, and the like) around a cylindricalmandrel. In some embodiments, an open lumen in the interior of thewire-framed cylinder is created, and the ends of the wire-framedcylinder are open. In some embodiments, the cup frame is formed so thatit can be radially compressed to a low-profile configuration forplacement in a delivery catheter or sheath.

At operation 330, the one or more wires can be optionally formed into acoil. As described above with reference to FIG. 7, in some embodimentsthe wire used to form the coil is the same wire(s) that the cup frame ismade of. In some embodiments, the wire used to form the coil is a wirethat is separate from the wire(s) that the cup frame is made of. Varioustypes of coils can be formed (see, e.g., FIGS. 6A-6F).

At operation 340, if the occlusion device being made includes theoptional coil, the one or more wires used to form the coil can beelongated. In some cases, the coil is elongated by stretching the coil.That is, the coil can be elongated by pulling apart or displacing theends of the coil in opposite directions. In some embodiments, theelongated coil is substantially linear. In some embodiments, theelongated coil has an undulating shape that is reminiscent of the coiledshape of the wire. The elongated coil has a length that it greater thanthe coil prior to elongation. The elongated coil has a diameter that isless than the overall diameter of the coil prior to elongation.

At operation 350, a membranous material is affixed to the shape memorywire. In some embodiments, the membranous material is a tube thatsurrounds the cup frame and the optional elongated coil. In someembodiments, the tube is an extruded film material. In some embodiments,the tube is made by winding a membranous strip. In some embodiments, thetube is knitted or woven. In some embodiments, the membranous materialis a strip of material. In some embodiments, the membranous material isa strip that is wound onto or folded over the cup frame and optionalelongated coil. In some embodiments, the membranous material is affixedto the wire by an adhesive, by friction, by an interference fit, or byweaving the elongated coil within the membranous material—to name someexamples.

The membranous material is applied to the wire such that a cup-shapedportion of membranous material is affixed to the cup frame. In someembodiments, the membranous cup-shaped portion is located at and affixedto the proximal end of the cup frame. In some embodiments, themembranous cup-shaped portion is formed by simply gathering and cinchingthe membranous tube at the proximal end (see, e.g., FIG. 8). A clipdevice, purse string sutures, or similar methods can be used to cinchclosed the membranous tube to create the cup-shaped portion. In someembodiments, the membranous cup-shaped portion can be sewn or cohered tocreate a conical, semispherical, cylindrical, or other similarthree-dimensional cup-like shape.

At operation 360, optionally, fringes of membranous material can beformed on the occlusion device. In some embodiments, the fringes can beoptionally formed of (or added onto) the membranous material affixed tothe optional elongated coil. In some embodiments, the fringes are formedby incising the membranous material. In some embodiments, the fringesare an additional portion of membranous material that is affixed to theocclusion device.

At operation 370, the optional elongated coil with the affixedmembranous material can be allowed to recoil to a contracted coil shape.In some embodiments, the elongated coil will be biased to contract to acoiled shape as a result of operation 330. In some embodiments, thisoperation will cause the membranous material that is affixed to theelongated coil to also become be rearranged, i.e., the membranousmaterial will become bunched up or compressed into a wad.

FIG. 13 depicts an example method 400 for implanting an occlusion deviceat a target site within a bodily lumen, cavity, vessel, or organ. Themethod 400 is a transcatheter or percutaneous method for implanting anocclusion device.

The method 400 starts at operation 410 where an occlusion device with ashape memory material wire and membranous material is provided. Forinstance, the occlusion device can be any of the embodiments ofocclusion devices described herein.

At operation 420, a deployment system is provided. In some embodimentsof method 400, the deployment system is like the deployment system 100described in reference to FIGS. 10A-10D. In some embodiments of method400, other types of deployment systems for percutaneous device deliveryare utilized.

At operation 430, the occlusion device is configured in a pre-deployedstate in the deployment system. In some occlusion device embodiments,the pre-deployed state is a low-profile state achieved by deflecting theshape memory wire of the device. For example, occlusion devices with acoil can be configured in a pre-deployed low-profile state by stretchingthe coil (i.e., displacing and maintaining the positions of the ends ofthe coil in opposite directions). Occlusion device embodiments having acup frame can be configured in a pre-deployed low-profile state byradially compressing the cup frame portion. An occlusion device that isconfigured in a pre-deployed low-profile state can be placed within acomponent of the deployment system. For example, in some embodiments,the occlusion device can be placed within a lumen of a delivery catheteror sheath.

At operation 440, the occlusion device is delivered to a target siteusing the deployment system. The target site may be a particularlocation in a bodily lumen, cavity, vessel, or organ. In someembodiments, the delivery system is used to traverse the vasculature ofa patient to a target site. In some embodiments, the delivery system issteerable using a controller device that is operable by a clinician. Insome embodiments, a system for visualizing the position of thedeployment system and/or occlusion device is used (e.g., an x-rayfluoroscopy system).

At operation 450, the occlusion device is deployed at the target sitewithin the bodily lumen, cavity, vessel, or organ. In some embodiments,a pusher catheter is used to eject the occlusion device from a lumen ofa delivery catheter. In some embodiments, the occlusion devicereconfigures its size and shape as a result of the deployment from thedelivery catheter. In some embodiments, the reconfigured occlusiondevice is positioned within the bodily lumen, cavity, vessel, or organso as to reduce or eliminate fluid flow in the area of the occlusiondevice.

Some embodiments of the occlusion devices provided herein, and methodsof their manufacture and use, are further illustrated by the examplesbelow.

EXAMPLE 1

Manufacture of a Fringed Occlusion Device

A fringed occlusion device for blocking fluid flow through a lumen in abodily tissue was produced as follows.

A NiTi wire was heat-treated to memorize and assume a helical coil shapewhen deployed. The wire was extended by stretching it to a linearconfiguration. A polyflourocarbon (ePTFE) sheet was wrapped in twolayers around the wire and thermally bonded (in a 320° C. oven for threeminutes) to the wire.

A loose, unsecured edge of the polymer sheet was left open along thelength of the wire. Random cuts were made into the loose edge to form anexternal fringe along the length of the device.

EXAMPLE 2

Manufacture of a Fringed Occlusion Device

A fringed occlusion device for blocking blood flow through a lumen in abodily tissue was produced as follows.

A NiTi wire was heat-treated to memorize and assume a helical coil shapewhen deployed. The wire was extended by stretching to a linearconfiguration. A polyflourocarbon (ePTFE) sheet was wrapped in a layeraround the wire and thermally treated by thermally bonding (in a 320° C.oven for three minutes) to the wire. Random cuts were made into the tubeto form an external fringe along the length of the device.

The wire was allowed to assume a partially pre-deployed shape (loosecoil). The cuts were sufficient in number and location to relieve thetension exerted on the tube by the coil so it could be stretched forloading into a delivery catheter.

EXAMPLE 3

Occlusion Using a Fringed Occlusion Device

Occlusion of a lumen (vascular lumen model) by a fringed occlusiondevice manufactured as described in Example 2 was tested under theconditions noted below.

Testing Pressure (target 125 mm Hg): 125 mm Hg Delivery Catheter ID: 6french Pressure Post Deployment: 72 mm Hg

Substantially complete occlusion of the lumen without migration of thedevice at post-deployment pressures of 1.4 psi was demonstrated. Thedevice was successfully retrieved intact from the lumen followingtesting.

EXAMPLE 4

Manufacture of an Occlusion Device with a Fluid Capture Cup

An occlusion device with a fluid capture cup was produced as follows:

A nitinol wire was heat-treated to memorize and assume a helical coilshape when deployed. While it its deployed, helical coil state, the openend of a polyfluorocarbon cup was secured by thermally bonding to atleast one full turn of the coiled wire.

EXAMPLE 5

Manufacture of an Occlusion Device with a Fluid Capture Cup

An occlusion device with a fluid capture cup was produced as follows:

A nitinol wire was heat-treated to memorize and assume a helical coilshape when deployed. With the wire in it its longitudinally extendedstate, a sheet of ePTFE coated with FEP granules with a conical closedend was wrapped around the wire and heat-secured to it (in a 320° C.oven for three minutes). The tip of the conical closed end was a solidplug that was pierced to form a through bore for insertion of a loopedsuture.

EXAMPLE 6

Fluid Flow Into an Occlusion Device with a Fluid Capture Cup

Capture of axial fluid flow through the center of the coil of the devicedescribed in Example 5 was tested in a model of fluid dynamics.

At 125 mm Hg, fluid flow through an 8 mm luminal space (tube) causedcomplete eversion of the cup into the center of the coil. Blood capturedwithin the everted cup caused it to radially expand, pressing the outersurface of the cup against the inner surface of the coil.

While this specification contains many specific implementation details,these should not be construed as limitations on the scope of anydevices, methods, and systems discussed herein, but rather asdescriptions of features that may be specific to particular embodiments.Certain features that are described in this specification in the contextof separate embodiments can also be implemented in combination in asingle embodiment. Conversely, various features that are described inthe context of a single embodiment can also be implemented in multipleembodiments separately or in any suitable subcombination. Moreover,although features may be described above as acting in certaincombinations and even initially claimed as such, one or more featuresfrom a claimed combination can in some cases be excised from thecombination, and the claimed combination may be directed to asubcombination or variation of a subcombination.

Numerous characteristics and advantages have been set forth in thepreceding description, including various alternatives together withdetails of the structure and function of the devices and/or methods. Thedisclosure is intended as illustrative only and as such is not intendedto be exhaustive. It will be evident to those skilled in the art thatvarious modifications may be made, especially in matters of structure,materials, elements, components, shape, size and arrangement of partsincluding combinations within the principles of the disclosure, to thefull extent indicated by the broad, general meaning of the terms inwhich the appended claims are expressed. To the extent that thesevarious modifications do not depart from the spirit and scope of theappended claims, they are intended to be encompassed therein.

What is claimed is:
 1. An implantable occlusion device comprising: awire having a longitudinal length and shape memory properties, andadapted to be reconfigured from a pre-deployed state to a deployed statewherein the wire recoils longitudinally and expands radially within alumen in a bodily tissue to define an interior region, and a flexiblepolymer sheet that is disposed around the wire such that the flexiblepolymer sheet defines a longitudinal fold, the sheet defining a wiresleeve portion extending along the fold, and an excess portion extendingalong the wire sleeve portion, the wire extending longitudinally withinthe wire sleeve portion, wherein the excess portion includes an externalfringe, the external fringe including a first, uncut portion of thesheet disposed adjacent the wire and extending continuously along atleast a portion of a longitudinal length of the wire and a second cutportion extending from the uncut portion away from the wire, the cutportion defining a plurality of individual fringes separated from anadjacent one of the plurality of individual fringes by a cut line, thecut lines of the plurality of individual fringes extending from the wireto a free edge of the second cut portion, and the external fringeextending along at least a portion of a length of the sheet such thatthe external fringe is adapted to project from the recoiled wire to fillthe interior region to promote occlusion of the lumen in the bodilytissue.
 2. The implantable occlusion device of claim 1, wherein theexternal fringe comprises an incised portion of the sheet.
 3. Theimplantable occlusion device of claim 1, wherein at least a portion ofthe fringe is non-integral to the sheet.
 4. The implantable occlusiondevice of claim 1, wherein the fringe extends substantially an entirelength of the wire.
 5. The implantable occlusion device of claim 1,wherein the sheet is attached to the wire at one or more locations onthe wire.
 6. The implantable occlusion device of claim 1, wherein thesheet comprises ePTFE.
 7. The implantable occlusion device of claim 1,further comprising an endothelization promoting agent, anti-inflammatoryagent, or a healing agent.
 8. The implantable occlusion device of claim1, further comprising one or more radiopaque markers.
 9. An implantableocclusion device comprising: a wire having shape memory properties andadapted to be reconfigured from a pre-deployed state to a deployed statewherein the wire recoils longitudinally and expands radially within alumen in a bodily tissue to define an interior region, and a flexiblepolymer tube that is disposed around the wire such that the flexiblepolymer tube defines a longitudinal fold, the lube defining a wiresleeve portion extending along the fold, and an excess portion extendingalong the wire sleeve portion, the wire extending longitudinally withinthe wire sleeve portion, wherein the excess portion includes an externalfringe, the external fringe including a first, uncut portion of the tubedisposed adjacent the wire and extending continuously along at least aportion of a longitudinal length of the wire and a second cut portionextending from the uncut portion away from the wire, the cut portiondefining a plurality of individual fringes separated from an adjacentone of the plurality of individual fringes by a cut line, the cut linesof the plurality of individual fringes extending from the wire to a freeedge of the second cut portion, and the external fringe extending alongat least a portion of a length of the tube such that the external fringeis adapted to project from the recoiled wire to fill the interior regionto promote occlusion of the lumen in the bodily tissue.
 10. Theimplantable occlusion device of claim 9, wherein at least a portion ofthe wire is located inside a lumen of the tube.
 11. The implantableocclusion device of claim 9, wherein the tube comprises a polymer stripthat is wrapped around at least a portion of the wire.
 12. Theimplantable occlusion device of claim 9, wherein the external fringecomprises an incised portion of the tube.
 13. The implantable occlusiondevice of claim 9, wherein at least a portion of the fringe isnon-integral to the tube.
 14. The implantable occlusion device of claim9, wherein the fringe extends substantially an entire length of thewire.
 15. The implantable occlusion device of claim 9, wherein thefringe has a length that extends beyond a length of the wire.
 16. Theimplantable occlusion device of claim 9, wherein the tube is attached tothe wire at one or more locations on the wire.
 17. The implantableocclusion device of claim 9, wherein the tube comprises ePTFE.
 18. Theimplantable occlusion device of claim 9, further comprising anendothelization promoting agent, anti-inflammatory agent, or a healingagent.
 19. The implantable occlusion device of claim 9, furthercomprising one or more radiopaque markers.
 20. A device for limitingfluid flow through a lumen in a bodily tissue, comprising: a frameincluding at least one wire and defining a proximal portion that is openand a distal portion, the frame being adapted to be reconfigured duringdeployment into the lumen from a pre-deployed state to a deployed state,the deployed state including the proximal portion expanding outwardly todefine an inner lumen and the distal portion bunching togetherlongitudinally and expanding outwardly within the lumen in the bodilytissue to define an interior region; a flexible polymeric materialdisposed about the distal portion of the frame such that the flexiblepolymeric material defines a longitudinal fold, the flexible polymericmaterial defining a wire sleeve portion extending along the fold, and anexcess portion extending along the wire sleeve portion, the distalportion of the frame extending longitudinally within the wire sleeveportion, the excess portion including an external fringe that is adaptedto project from the bunched distal portion of the wire to fill theinterior region and promote occlusion of the lumen in the bodily tissue;and a flexible polymeric cup, wherein the flexible polymeric cupincludes an open end affixed to the proximal portion of the frame,wherein the flexible polymeric cup is adapted to be reconfigured duringdeployment into the lumen from a pre-deployed state to an everted statein which the polymeric cup is extends distally within the inner lumen ofthe proximal portion of the frame, and wherein the flexible polymericcup in the everted state is adapted to limit fluid flow through thelumen.
 21. The device of claim 20, wherein the flexible polymeric cup isformed from a sheet of polymeric material.
 22. The device of claim 20,wherein the flexible polymeric cup is formed from a tube of polymericmaterial.
 23. The device of claim 20, wherein the flexible polymeric cupcomprises ePTFE.
 24. The device of claim 20, further comprising one ormore radiopaque markers.
 25. The device of claim 20, wherein the framedefines a wire-framed cylinder having a first open end and a second openend.